C82.22
Follicular lymphoma grade III, unspecified, intrathoracic lymph nodes
Clinical Classification Guidelines
Medical Intelligence & Overview
Follicular lymphoma is a type of non-Hodgkin lymphoma that originates in lymphatic tissue. It is characterized by the slow growth of cancerous lymphocytes that form follicle-like structures within lymph nodes. Specifically, grade III follicular lymphoma indicates a higher level of abnormal cell appearance and growth activity, often suggesting a more aggressive form of the disease. When it affects the intrathoracic lymph nodes — those located within the chest — it may impact breathing and other vital functions. Understanding this diagnosis can help patients and caregivers grasp the condition, its progression, and potential management strategies.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting lymphocyte development Age-related changes in the immune system Environmental exposures such as chemicals or certain poisons A family history of lymphomas or other hematologic cancers Immune system dysregulation or infections that impact lymphatic tissue
Key Symptoms: Swelling or painless enlargement of lymph nodes in the chest Persistent cough or coughing up blood (hemoptysis) Shortness of breath or difficulty breathing Chest discomfort or pressure sensation Unexplained weight loss Fever and night sweats
Diagnostic & Treatment
Diagnosis Path: Diagnosing follicular lymphoma grade III involves a combination of clinical assessments and laboratory procedures. Initially, healthcare providers will perform a physical examination and review the patient's medical history. Imaging tests such as CT scans or PET scans are used to identify enlarged lymph nodes within the chest. A definitive diagnosis requires a biopsy of the affected lymph node, where tissue is examined microscopically to determine the grade and subtype of lymphoma. Additional blood tests and molecular studies may be conducted to assess disease spread and genetic features of the cancer cells.
Treatment Protocols: Chemotherapy: Using drugs to kill or control the growth of lymphoma cells. Immunotherapy: Employing medications like monoclonal antibodies to boost the immune system's ability to target cancer cells. Radiation therapy: Targeted radiation may be used for localized disease or symptom relief. Targeted therapies: Drugs that specifically interfere with molecular pathways involved in lymphoma growth. Monitoring and watchful waiting: In some cases, especially with indolent disease, active surveillance might be recommended before initiating treatment.
Clinical Advice & FAQs
Billing Guidance
Is C82.22 a billable ICD-10 code?
Yes, C82.22 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C82.22?
Clinical documentation must specify the nature of Follicular lymphoma grade III, unspecified, intrathoracic lymph nodes and any associated comorbidities for accurate reporting.
Cite this Clinical Reference